Your browser doesn't support javascript.
loading
Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer.
Fox, Eric; Oliver, Thomas; Rowe, Melissa; Thomas, Sunil; Zakharia, Yousef; Gilman, Paul B; Muller, Alexander J; Prendergast, George C.
Afiliación
  • Fox E; Department of Hematology-Oncology, Lankenau Medical Center, Wynnewood, PA, United States.
  • Oliver T; Department of Hematology-Oncology, Lankenau Medical Center, Wynnewood, PA, United States.
  • Rowe M; Department of Hematology-Oncology, Lankenau Medical Center, Wynnewood, PA, United States.
  • Thomas S; Lankenau Institute for Medical Research, Wynnewood, PA, United States.
  • Zakharia Y; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.
  • Gilman PB; Department of Hematology-Oncology, Lankenau Medical Center, Wynnewood, PA, United States.
  • Muller AJ; Lankenau Institute for Medical Research, Wynnewood, PA, United States.
  • Prendergast GC; Lankenau Institute for Medical Research, Wynnewood, PA, United States.
Front Oncol ; 8: 370, 2018.
Article en En | MEDLINE | ID: mdl-30254983
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos